EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discovery

EXCLUSIVE: ImmunoPrecise Antibodies' Subsidiary Releases Software With Customizable Interface For AI-Driven Drug Discovery
benzinga.com

by Vandana Singh • 10 months ago

On Monday, ImmunoPrecise Antibodies Ltd NASDAQ:IPA announced that its subsidiary, BioStrand, has released the commercial version of LENSai API

Summarized in 80 words

Latest AI Tools

More Tech Bytes...